Topic
Bleeding Risk
6 published works
Drug & Device Law
Good Testimony from Neutral Prescriber Leads to Summary Judgment in Plavix Litigation
We’ve posted a lot about Plavix recently but all in the context of the Supreme Court’s decision in BMS v. Superior Court on personal jurisdiction. So, we don’t blame you…
Mass Torts Law Blog
Latest Developments in the Xarelto Litigation
Xarelto (rivaroxaban) is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in July 2011 to prevent strokes in patients who received hip and knee…
Dangerous Drugs & Medical Devices
Study shows Xarelto carries higher risk for bleeding than industry standard
By Jared Fink
Here, we discuss a study titled “Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in…
Dangerous Drugs & Medical Devices
2014 – More Research Shows Xarelto Linked to Major Bleeding Events
By Jared Fink
In recent years, a number of studies have shown that the anticoagulant drug Xarelto (rivaroxaban) is linked to increased risk for major bleeding events. Here, we discuss one such study,…
Dangerous Drugs & Medical Devices
2014 – Xarelto linked to higher risk for bleeding
By Jared Fink
In the United States alone, about four million prescriptions for anticoagulant drugs are filled each year. With the use of each of these drugs comes the risk for internal bleeding,…
Mass Torts Law Blog
First Two Bellwether Trials in Pradaxa Litigation Scheduled
The use of Pradaxa has been linked to serious injury. There are nearly 2,000 cases currently pending in federal court in the Southern District of Illinois. Pradaxa is a blood thinner that…